Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$33.3M Buy
587,928
+484,490
+468% +$27.2M 0.02% 682
2014
Q2
$5.71M Sell
103,438
-141,060
-58% -$7.7M ﹤0.01% 1837
2014
Q1
$13.2M Sell
244,498
-13,939
-5% -$722K 0.01% 1049
2013
Q4
$12.3M Buy
258,437
+120,311
+87% +$5.5M 0.01% 1105
2013
Q3
$6.28M Sell
138,126
-41,501
-23% -$1.89M 0.01% 1518
2013
Q2
$7.96M Buy
+179,627
New +$8.02M 0.01% 1214

Other funds holding MRK

UBS's MRK Position: Q3 2014 in Review

UBS increased its Merck (MRK) stake by 13% in Q3 2014, buying an estimated $76.6M and bringing the position to 11,736,426 shares worth $664M. The position accounts for 0.49% of the portfolio, ranked #22.

UBS first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. 1,618 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • UBS held 11,736,426 shares of Merck worth $664M as of Q3 2014.
  • UBS bought 1,364,523 Merck shares in Q3 2014, an estimated $76.6M.
  • Merck made up 0.49% of UBS's portfolio in Q3 2014, its #22 holding.
  • UBS first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • 1,618 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.